Phase II study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus

Anti-Cancer Drugs

Volumn 12, Issue 6, 2001, Pages 513-517

  Polee, M B ^a   Kok, T C ^a   Siersema, P D ^a   Tilanus, H W ^a   Splinter, T A W ^a   Stoter, G ^a   Van Der Gaast, A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

5 Fluorouracil; Chemotherapy; Cisplatin; Esophageal cancer; Etoposide; Folinic acid

Indexed keywords

CISPLATIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; ESOPHAGUS CANCER; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ETOPOSIDE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED;

EID: 0034926576     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200107000-00004     Document Type: Article

References (26)

1. Surgical therapy of esophageal carcinoma
2. A 15-year review of esophagectomy for carcinoma of the esophagus and cardia
3. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer
4. Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus
5. Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell esophageal cancer
6. Contributions of chemotherapy in the treatment of carcinoma of the esophagus: Results and commentary
7. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer Evidence in terms of response rate
8. Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal and pancreatic cancer
9. 5-Fluorouracil and folinic acid in adenocarcinoma of the esophagus or esophago-gastric junction area
10. A phase II study of 5-fluorouracil and leucovorin in advanced carcinoma of the esophagus
11. Cisplatin and etoposide in esophageal cancer: A phase II study
12. Low dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves
13. Etoposide enhances the antitumor effects of cisplatin in gastric cancer cells
14. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer
15. Palliation of malignant dysphagia from esophageal cancer
16. Prospective randomized trial comparing brachytherapy and laser photoablation for palliation of esophageal cancer
17. Quality of life measurement in patients with esophageal cancer
18. A prospective longitudinal study examining the quality of life in patients with esophageal cancer
19. 5-Fluorouracil, folinic acid, etoposide, and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the esophagus
20. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial
21. Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction
22. Definitive chemo-radiotherapy for T4 and or M1 lymph node squamous cell carcinoma of the esophagus
23. A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: A preliminary report
24. Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced esophageal cancer
25. Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer